Table 1.
Clinical and demographic characteristics of melanoma patients and controls.
| Demographic Data | Controls 1 (N = 200) | Melanoma Patients (N = 233) |
|---|---|---|
| Age (years, Mean ± SD) | 51 ± 17 | 53 ± 15 |
| Gender (Male) | 92 (46%) | 112 (48%) |
| Histological subtypes | ||
| SSM | 162 (69%) | |
| NM | 29 (12%) | |
| LMM | 16 (7%) | |
| ALM | 13 (6%) | |
| Other 2 | 13 (6%) | |
| Clinical characteristics | ||
| Tumor thickness | ||
| ≤1 mm | 128 (55%) | |
| >1 mm | 104 (45%) | |
| Ulceration at primary lesion | ||
| Yes | 44 (20%) | |
| No | 173 (80%) | |
| SLN metastasis | ||
| Yes | 22 (16%) | |
| No | 119 (84%) | |
1 200 sex- and age-matched healthy Caucasian individuals of the same ethnic origin were included (92 men and 108 women). SSM: superficial spreading melanoma; NM: nodular melanoma; LMN: lentigo maligna melanoma; ALM: acral lentiginous melanoma; SLN: sentinel lymph node. 2 Other: Melanoma “in situ” (n = 11, 5%); Desmoplastic melanoma (n = 1, 0.5%); Spitzoid melanoma (n = 1, 0.5%).